General Information
Revision date
2011-11-14
Product name
Sildenafil Citrate
Chemical name
Sildenafil Citrate
CAS No.
171599-83-0
1.2.1 Relevant identified uses
To be used only for scientific research and development. Not for use in humans or animals
Icons in SDS
Company Information
company name
Toronto Research Chemicals
e-mail address of the competent person responsible for the Safety Data Sheet
orders@trc-canada.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H332, H335, H336, H362, H402, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1/2.2 Classification of the Substance or Mixture and Label Elements
Classification according to GHS
According to EU Regulation 1272/2008 and US OSHA 1910.1200) Acute Toxicity, Inhalation (Category 4) Skin Irritation (Category 2) Eye Damage/Irritation (Category 2A) Specific Target Organ Toxicity, Single Exposure; Respiratory Tract Irritation (Category 3) Specific Target Organ Toxicity, Single Exposure; Central nervous system (Category 3) Reproductive Toxicity, Effects on or via Lactation (Additional Category) Hazardous to the Aquatic Environment, Acute Hazard (Category 3) Hazardous to the Aquatic Environment, Long-Term Hazard (Category 3)
Hazard statements
Identification (According to EU Regulation 1272/2008 and US OSHA 1910.1200) H332 Harmful if inhaled. H315 Causes skin irritation. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H336 May cause drowsiness or dizziness. H362 H402 May cause harm to breast-fed children. H412 Harmful to aquatic life. Harmful to aquatic life with long lasting effects.
Signal word
Warning
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray P280 Wear protective gloves/protective clothing/eye protection/face protection. P305/P351/P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.
2.3 Other hazards
No data available.
